Skip to main content

Illinois IGB

Zeynep Madak-Erdogan

ER-positive breast cancer presents differing metabolic signatures in African American, white women

September 11, 2023

September 11, 2023


Related Articles

Three IGB members assume new Cancer Center at Illinois leadership roles

September 5, 2023

The Cancer Center at Illinois (CCIL) is reshaping its core leadership team, including three transitions in leadership positions by IGB members.

These changes reflect the institute’s continued evolution and build upon its history of research and education excellence. The new positions also underscore the CCIL’s strong commitment to leadership development and the growth of some of the institute’s most visionary members. Each new appointee contributed significantly to CCIL research, education, and outreach initiatives.


September 5, 2023


Related Articles

Treatment of liver metastases in breast cancer patients improved by low-carb diets

March 28, 2022

A new study by Zeynep Madak-Erdogan (CGD/EIRH/GSP) Associate Professor of Food Science and Human Nutrition and Cancer Center at Illinois Education Program Leader, and her team have found a new mechanism of endocrine resistance in breast cancers metastasized to the liver.


March 28, 2022


Related Articles

PFAS exposure, high-fat diet drive prostate cells’ metabolism into pro-cancer state

November 12, 2021

Exposure to PFAS – a class of synthetic chemicals utilized in food wrappers, nonstick cookware and other products – reprograms the metabolism of benign and malignant human prostate cells to a more energy efficient state that enables the cells to proliferate at three times the rate of nonexposed cells, a new study in mice found.


November 12, 2021


Related Articles

Postmenopausal women may benefit from estrogen compound research

October 28, 2021

Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to cirrhosis and liver failure. Hormone replacement therapy (HRT) is an effective treatment, but it carries increased risk of breast cancer, uterine cancers, and cardiovascular disease.


October 28, 2021


Related Articles

New markers for coronary microvascular disease identified

July 1, 2021

Although cardiovascular disease is the main cause of illness among women in the U.S., certain conditions such as coronary microvascular disease (CMD) cannot be easily diagnosed. In a new study, researchers at the University of Illinois Urbana-Champaign have identified specific biomarkers for CMD, which might reduce future hospitalizations.


July 1, 2021


Related Articles

Gene biomarkers indicate liver toxicity quickly and accurately

December 18, 2020

When agrochemical and pharmaceutical companies develop new products, they must test extensively for potential toxicity before obtaining regulatory approval. This testing usually involves lengthy and expensive animal studies.

A research team at University of Illinois has developed a gene biomarker identification technique that cuts the testing process down to a few days while maintaining a high level of accuracy.


December 18, 2020


Related Articles

Nelson awarded $4.5M to study prevention, treatment of breast cancer

October 30, 2020

Professor of Molecular and Integrative Physiology Erik Nelson (ACPP) has won a $4.5M Era of Hope Scholar Award from the United States Department of Defense (DoD) Breast Cancer Research Program (BCRP). This prestigious award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer research. Recipients of the Era of Hope Scholar Award are leaders and visionaries in their respective field who go beyond conventional thinking to change the current landscape of breast cancer research and therapy.


October 30, 2020


Related Articles

BRIDGE-ing the gap between diagnostics and gestational diabetes

January 6, 2020

As a result of intersecting research interests in women’s health, a new collaboration was forged between Zeynep Madak-Erdogan (GSP/ONC-PM), Assistant Professor in Food Science and Human Nutrition, and Justina Zurauskiene (ONC-PM), Birmingham-Illinois Partnership for Discovery, Engagement and Education (BRIDGE) fellow and fellow at the Institute of Cancer and Genomic Sciences in Birmingham, England. Founded in 2014, the BRIDGE program is an ongoing partnership between the University of Birmingham and the University of Illinois at Urbana-Champaign.


January 6, 2020


Related Articles

Subscribe to Zeynep Madak-Erdogan